What is Crescent Capital Bdc Inc's earnings per share (EPS)?

Crescent Capital Bdc Inc (CCAP) reported diluted earnings per share of $1.81 for fiscal year 2025. This represents a -24.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Crescent Capital Bdc Inc Financials

CCAP

Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE December

This page shows Crescent Capital Bdc Inc (CCAP) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CCAP FY2025 2026-05-13

Crescent Capital BDC’s leveraged portfolio-income model is visible in stable asset funding but shrinking equity absorption.

From FY2024 to FY2025, net income fell from $73.6M to $34.5M while operating cash flow improved from $58.9M to $74.7M; that gap says reported results were more volatile than the cash actually coming off the asset base. Because dividends paid were $67.8M in FY2025, the payout was covered by cash generation even as return on equity slipped to 4.9%.

The balance sheet became more levered through equity shrinkage, not through a borrowing surge: long-term debt was still about $873.8M in FY2025 while equity fell to $706.0M. That pushed debt-to-equity to 1.2x, meaning less book-value cushion is absorbing changes in portfolio values.

Over the last three fiscal years, distributions have run heavier than retained profit: dividends exceeded net income in both FY2024 and FY2025, and retained earnings sank further to -$251.0M. The operating model therefore looks built to pass through cash rather than accumulate much capital internally.

Financial Health Signals

Financial Profile 17/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Crescent Capital Bdc Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Leverage

Crescent Capital Bdc Inc carries a low D/E ratio of 1.24, meaning only $1.24 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 77/100, indicating a strong balance sheet with room for future borrowing.

Returns

Crescent Capital Bdc Inc generates a 4.9% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 28/100. This is down from 9.9% the prior year.

Piotroski F-Score Neutral

4/9

Crescent Capital Bdc Inc passes 4 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass.

Earnings Quality Cash-Backed

2.17x

For every $1 of reported earnings, Crescent Capital Bdc Inc generates $2.17 in operating cash flow ($74.7M OCF vs $34.5M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage At Risk

-1.7x

Crescent Capital Bdc Inc earns $-1.7 in operating income for every $1 of interest expense (-$98.7M vs $57.4M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

N/A

EBITDA

N/A

Net Income

$34.5M

YoY-53.1%

5Y CAGR-8.8%

Crescent Capital Bdc Inc reported $34.5M in net income in fiscal year 2025. This represents a decrease of 53.1% from the prior year.

EPS (Diluted)

$1.81

YoY-24.6%

5Y CAGR+0.1%

Crescent Capital Bdc Inc earned $1.81 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 24.6% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$5.0M

YoY-50.2%

5Y CAGR+23.6%

Crescent Capital Bdc Inc held $5.0M in cash against $873.8M in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

37M

YoY-0.2%

Crescent Capital Bdc Inc had 37M shares outstanding in fiscal year 2025. This represents a decrease of 0.2% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

Return on Equity

4.9%

YoY-5.1pp

5Y CAGR-4.9pp

Crescent Capital Bdc Inc's ROE was 4.9% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 5.1 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

$1.3M

5Y CAGR-9.6%

Crescent Capital Bdc Inc spent $1.3M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Capital Expenditures

N/A

CCAP Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	-$98.7M+7.6%	-$106.8M-6.5%	-$100.3M-76.5%	-$56.8M-28.8%	-$44.1M-65.3%	-$26.7M
Interest Expense	$57.4M-8.5%	$62.8M+6.8%	$58.7M+84.3%	$31.9M+61.3%	$19.8M+27.6%	$15.5M
Income Tax	$6K-96.1%	$155K+400.0%	$31K+109.5%	-$326K-118.8%	$1.7M+3496.1%	-$51K
Net Income	$34.5M-53.1%	$73.6M-12.2%	$83.8M+439.4%	$15.5M-81.4%	$83.6M+53.0%	$54.7M
EPS (Diluted)	$1.81-24.6%	$2.40+4.3%	$2.30+19.2%	$1.93+15.6%	$1.67-7.2%	$1.80

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	-$21.9M	N/A	-$24.1M+6.1%	-$25.7M-2.8%	-$25.0M	N/A	-$27.4M-2.3%	-$26.8M
Interest Expense	$13.7M	N/A	$13.9M-8.4%	$15.2M+3.5%	$14.6M	N/A	$16.1M+1.1%	$15.9M
Income Tax	N/A	N/A	$0	$0-100.0%	$6K	N/A	$155K	$0
Net Income	-$15.5M	N/A	$7.1M-52.7%	$15.0M+284.6%	$3.9M	N/A	$15.3M-25.1%	$20.4M
EPS (Diluted)	$0.42	N/A	$0.460.0%	$0.46+2.2%	$0.45	N/A	$0.64+8.5%	$0.59

CCAP Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$1.6B-2.1%	$1.7B+1.8%	$1.6B+24.9%	$1.3B-1.1%	$1.3B	N/A
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$5.0M-50.2%	$10.1M+30.2%	$7.8M+21.6%	$6.4M-36.5%	$10.1M+476.7%	$1.7M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$916.1M+0.1%	$915.6M+3.5%	$884.8M+28.2%	$690.3M+3.7%	$665.5M	N/A
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	$873.8M-0.2%	$875.8M+3.7%	$844.8M+29.1%	$654.5M+3.7%	$631.0M	N/A
Total Equity	$706.0M-4.7%	$740.6M-0.3%	$742.6M+21.2%	$612.5M-6.1%	$652.3M+16.5%	$560.0M
Retained Earnings	-$251.0M-14.9%	-$218.5M+2.2%	-$223.3M-257.4%	-$62.5M-349.4%	-$13.9M	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$1.6B-0.3%	$1.6B-0.3%	$1.6B-1.6%	$1.7B-0.7%	$1.7B+0.6%	$1.7B+0.7%	$1.6B-1.6%	$1.7B
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$6.1M+21.7%	$5.0M-12.8%	$5.8M-40.6%	$9.7M-19.1%	$12.0M+18.8%	$10.1M-40.7%	$17.1M+55.1%	$11.0M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$943.6M+3.0%	$916.1M+0.3%	$913.6M-1.7%	$929.7M-1.0%	$939.4M+2.6%	$915.6M+2.2%	$896.2M-2.6%	$920.0M
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	$907.1M+3.8%	$873.8M-0.2%	$875.3M-1.4%	$887.3M-1.7%	$903.0M+3.1%	$875.8M+2.2%	$857.2M-2.6%	$879.9M
Total Equity	$674.0M-4.5%	$706.0M-1.1%	$714.1M-1.5%	$724.7M-0.3%	$727.1M-1.8%	$740.6M-1.1%	$748.8M-0.5%	$752.4M
Retained Earnings	-$282.0M-12.4%	-$251.0M-2.6%	-$244.7M-4.4%	-$234.4M-1.0%	-$232.0M-6.2%	-$218.5M-0.6%	-$217.1M-1.7%	-$213.5M

CCAP Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$74.7M+26.8%	$58.9M-36.2%	$92.3M+230.2%	$28.0M+117.7%	-$157.7M-155.1%	-$61.8M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	-$82.5M-89.9%	-$43.5M+48.9%	-$85.0M-147.0%	-$34.4M-120.7%	$166.3M+163.1%	$63.2M
Dividends Paid	$67.8M-9.9%	$75.2M+16.6%	$64.5M+16.8%	$55.3M+15.8%	$47.7M+12.0%	$42.6M
Share Buybacks	$1.3M	N/A	N/A	N/A	N/A	$2.2M

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	-$23.8M-205.1%	$22.6M-26.4%	$30.8M-15.6%	$36.4M+340.9%	-$15.1M-423.6%	-$2.9M-106.2%	$46.9M+290.5%	-$24.6M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	$18.8M+199.2%	-$18.9M+34.9%	-$29.1M+29.0%	-$40.9M-745.2%	$6.3M+27.7%	$5.0M+111.0%	-$45.3M-257.3%	$28.8M
Dividends Paid	$15.5M-0.2%	$15.6M-10.6%	$17.4M-0.1%	$17.4M0.0%	$17.4M-4.1%	$18.2M-3.9%	$18.9M-1.9%	$19.3M
Share Buybacks	$1.0M0.0%	$1.0M	N/A	N/A	N/A	N/A	N/A	N/A

CCAP Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	4.9%-5.1pp	9.9%-1.3pp	11.3%+8.8pp	2.5%-10.3pp	12.8%+3.1pp	9.8%
Return on Assets	2.1%-2.3pp	4.5%-0.7pp	5.1%+4.0pp	1.2%-5.2pp	6.3%	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	1.24+0.1	1.18+0.0	1.14+0.1	1.07+0.1	0.97	N/A
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	-2.3%	N/A	1.0%-1.1pp	2.1%+1.5pp	0.5%	N/A	2.0%-0.7pp	2.7%
Return on Assets	-1.0%	N/A	0.4%-0.5pp	0.9%+0.7pp	0.2%	N/A	0.9%-0.3pp	1.2%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	1.35+0.1	1.24+0.0	1.230.0	1.22-0.0	1.24+0.1	1.18+0.0	1.14-0.0	1.17
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Similar Companies

Blackrock Tcp Capital Corp TCPC

$308.8M

MSC INCOME FUND INC MSIF

$532.4M

Western Asset Emerging Markets Debt Fund Inc EMD

$608.0M

Invesco Senior Income Trust VVR

$464.9M

BlackRock Enhanced International Dividend Trust BGY

$512.9M

Frequently Asked Questions

Is Crescent Capital Bdc Inc profitable?

Yes, Crescent Capital Bdc Inc (CCAP) reported a net income of $34.5M in fiscal year 2025.

How much debt does Crescent Capital Bdc Inc have?

As of fiscal year 2025, Crescent Capital Bdc Inc (CCAP) had $5.0M in cash and equivalents against $873.8M in long-term debt.

What is Crescent Capital Bdc Inc's return on equity (ROE)?

Crescent Capital Bdc Inc (CCAP) has a return on equity of 4.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Crescent Capital Bdc Inc's operating cash flow?

Crescent Capital Bdc Inc (CCAP) generated $74.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Crescent Capital Bdc Inc's total assets?

Crescent Capital Bdc Inc (CCAP) had $1.6B in total assets as of fiscal year 2025, including both current and long-term assets.

Does Crescent Capital Bdc Inc buy back shares?

Yes, Crescent Capital Bdc Inc (CCAP) spent $1.3M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Crescent Capital Bdc Inc have outstanding?

Crescent Capital Bdc Inc (CCAP) had 37M shares outstanding as of fiscal year 2025.

What is Crescent Capital Bdc Inc's debt-to-equity ratio?

Crescent Capital Bdc Inc (CCAP) had a debt-to-equity ratio of 1.24 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Crescent Capital Bdc Inc's return on assets (ROA)?

Crescent Capital Bdc Inc (CCAP) had a return on assets of 2.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Crescent Capital Bdc Inc's Piotroski F-Score?

Crescent Capital Bdc Inc (CCAP) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Crescent Capital Bdc Inc's earnings high quality?

Crescent Capital Bdc Inc (CCAP) has an earnings quality ratio of 2.17x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Crescent Capital Bdc Inc cover its interest payments?

Crescent Capital Bdc Inc (CCAP) has an interest coverage ratio of -1.7x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Crescent Capital Bdc Inc?

Crescent Capital Bdc Inc (CCAP) scores 17 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.